254 related articles for article (PubMed ID: 32890758)
1. Involvement of noradrenergic and serotonergic systems in risk-based decisions between options of equivalent expected value in rats.
Cui RS; Ruan H; Liu LY; Li XW
Neurobiol Learn Mem; 2020 Nov; 175():107310. PubMed ID: 32890758
[TBL] [Abstract][Full Text] [Related]
2. Effects of noradrenergic and serotonergic systems on risk-based decision-making and center arena activity in open field in rats.
Cui R; Wang L; Liu L; Ruan H; Li X
Eur J Pharmacol; 2018 Dec; 841():57-66. PubMed ID: 30268663
[TBL] [Abstract][Full Text] [Related]
3. Noradrenergic modulation of risk/reward decision making.
Montes DR; Stopper CM; Floresco SB
Psychopharmacology (Berl); 2015 Aug; 232(15):2681-96. PubMed ID: 25761840
[TBL] [Abstract][Full Text] [Related]
4. Impaired flexibility in decision making in rats after administration of the pharmacological stressor yohimbine.
Schwager AL; Haack AK; Taha SA
Psychopharmacology (Berl); 2014 Oct; 231(20):3941-52. PubMed ID: 24647923
[TBL] [Abstract][Full Text] [Related]
5. Modulation of risk/reward decision making by dopaminergic transmission within the basolateral amygdala.
Larkin JD; Jenni NL; Floresco SB
Psychopharmacology (Berl); 2016 Jan; 233(1):121-36. PubMed ID: 26432096
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
Hadamitzky M; Feja M; Becker T; Koch M
Behav Pharmacol; 2009 Sep; 20(5-6):415-23. PubMed ID: 19730369
[TBL] [Abstract][Full Text] [Related]
7. Dissociable contributions by prefrontal D1 and D2 receptors to risk-based decision making.
St Onge JR; Abhari H; Floresco SB
J Neurosci; 2011 Jun; 31(23):8625-33. PubMed ID: 21653866
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of risk-based decision making.
St Onge JR; Floresco SB
Neuropsychopharmacology; 2009 Feb; 34(3):681-97. PubMed ID: 18668030
[TBL] [Abstract][Full Text] [Related]
9. Receptor-specific modulation of risk-based decision making by nucleus accumbens dopamine.
Stopper CM; Khayambashi S; Floresco SB
Neuropsychopharmacology; 2013 Apr; 38(5):715-28. PubMed ID: 23303055
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 2A receptors contribute to the regulation of risk-averse decisions.
Macoveanu J; Rowe JB; Hornboll B; Elliott R; Paulson OB; Knudsen GM; Siebner HR
Neuroimage; 2013 Dec; 83():35-44. PubMed ID: 23810974
[TBL] [Abstract][Full Text] [Related]
11. Orbitofrontal or accumbens dopamine depletion does not affect risk-based decision making in rats.
Mai B; Hauber W
Cogn Affect Behav Neurosci; 2015 Sep; 15(3):507-22. PubMed ID: 25860659
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal cortical contribution to risk-based decision making.
St Onge JR; Floresco SB
Cereb Cortex; 2010 Aug; 20(8):1816-28. PubMed ID: 19892787
[TBL] [Abstract][Full Text] [Related]
13. Monoaminergic modulation of decision-making under risk of punishment in a rat model.
Blaes SL; Orsini CA; Mitchell MR; Spurrell MS; Betzhold SM; Vera K; Bizon JL; Setlow B
Behav Pharmacol; 2018 Dec; 29(8):745-761. PubMed ID: 30394882
[TBL] [Abstract][Full Text] [Related]
14. Balancing risk and reward: a rat model of risky decision making.
Simon NW; Gilbert RJ; Mayse JD; Bizon JL; Setlow B
Neuropsychopharmacology; 2009 Sep; 34(10):2208-17. PubMed ID: 19440192
[TBL] [Abstract][Full Text] [Related]
15. The Abused Inhalant Toluene Impairs Medial Prefrontal Cortex Activity and Risk/Reward Decision-Making during a Probabilistic Discounting Task.
Braunscheidel KM; Okas MP; Hoffman M; Mulholland PJ; Floresco SB; Woodward JJ
J Neurosci; 2019 Nov; 39(46):9207-9220. PubMed ID: 31548237
[TBL] [Abstract][Full Text] [Related]
16. Effects of acute administration of nicotine, amphetamine, diazepam, morphine, and ethanol on risky decision-making in rats.
Mitchell MR; Vokes CM; Blankenship AL; Simon NW; Setlow B
Psychopharmacology (Berl); 2011 Dec; 218(4):703-12. PubMed ID: 21638222
[TBL] [Abstract][Full Text] [Related]
17. Noradrenergic contributions to cue-driven risk-taking and impulsivity.
Chernoff CS; Hynes TJ; Winstanley CA
Psychopharmacology (Berl); 2021 Jul; 238(7):1765-1779. PubMed ID: 33649970
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of dopaminergic manipulations on risky choice.
St Onge JR; Chiu YC; Floresco SB
Psychopharmacology (Berl); 2010 Aug; 211(2):209-21. PubMed ID: 20495787
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic and serotonergic modulation of anterior insular and orbitofrontal cortex function in risky decision making.
Ishii H; Ohara S; Tobler PN; Tsutsui K; Iijima T
Neurosci Res; 2015 Mar; 92():53-61. PubMed ID: 25481848
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological evidence that 5-HT
Adams WK; Barkus C; Ferland JN; Sharp T; Winstanley CA
Psychopharmacology (Berl); 2017 Oct; 234(20):3091-3104. PubMed ID: 28733811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
